LSHTM Professors Discuss How Industry-Favorable Policies Threaten Progress On NCDs

BMJ Opinion: Johanna Hanefeld and Benjamin Hawkins: NCDs — it’s time to embrace the evidence, not industry
Johanna Hanefeld, associate professor, and Benjamin Hawkins, assistant professor, both at the London School of Hygiene and Tropical Medicine, discuss recommendations from a recent report by the WHO’s Independent High-Level Commission on Noncommunicable Diseases (NCDs). The authors note, “The report is remarkable in the extent to which it reproduces a pro-business agenda. … Embracing actors from any health-harming industry is misguided given the scale of the current NCD crisis and their role within this. … The forthcoming U.N. High-Level Meeting on NCDs in September 2018 offers a perfect opportunity for the global policy community to redress this and change tack decisively on NCDs. Adopting clearer regulatory guidance — including for taxation of sugar, tobacco, and alcohol — should be the first decisive step towards a unified approach to tackling NCDs globally” (7/12).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.